Commentary RE: “Efficacy and Safety of a Dual Inhibitor of 5-Alpha-Reductase Types 1 and 2 (Dutasteride) in Men With Benign Prostatic Hyperplasia”

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)339-340
Number of pages2
JournalUrology
Volume145
DOIs
StatePublished - Nov 2020

Cite this